Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 13, 2019
Q BioMed and Chemveda have formalized a collaboration to continue the develop chemotherapy for the treatment of liver cancer and scale-up manufacturing of the cGMP product.
read more
Friday, September 13, 2019
GE Healthcare and Germfree are joining expertise to develop a fully integrated, expandable manufacturing solution for emerging biotherapeutics, including gene therapy.
read more
Friday, September 13, 2019
Meitheal announced the launch of the Company’s eight presentations of heparin sodium injection, USP in the US.
read more
Friday, September 13, 2019
Acura Pharmaceuticals has engaged Catalent to initiate manufacturing scale-up of LTX-03 Tablets to ultimately be used in clinical testing.
read more
Monday, September 16, 2019
Mallinckrodt has entered into a definitive agreement to sell its wholly owned subsidiary BioVectra to an affiliate of H.I.G. Capital for approximately $250 million.
read more
Monday, September 16, 2019
Experic has announced Denise Sabaday as vice president of business development.
read more
Thursday, September 19, 2019
PMRS has filed a petition asking the U.S. Court of Appeals for the District of Columbia Circuit to overturn the FDA's refusal to approve a new opioid capsule intended to deter abuse.
read more
Friday, September 20, 2019
The FDA has classified 3P facilities as acceptable for the manufacture of the target molecule, and appropriate for its commercialization in the US market, once the product is authorized.
read more
Monday, September 23, 2019
Pii has announced the commercial supply of Fulvestrant Injection 250mg/5ml drug product, which was recently approved by the FDA.
read more
Monday, September 23, 2019
Hikma Pharmaceuticals has launched a new prefilled syringe capability in the US through its affiliate, Hikma Pharmaceuticals USA Inc.
read more
Tuesday, September 24, 2019
The Cell and Gene Therapy Catapult celebrates the completion of six additional modules at its manufacturing center in Stevenage.
read more
Wednesday, September 25, 2019
Catalent and Minerva Neurosciences have entered into a commercial supply agreement for roluperidone, an investigational compound from Minerva, for symptoms of schizophrenia.
read more
Wednesday, September 25, 2019
The FDA has announced a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz used to decrease the amount of acid created by the stomach.
read more
Thursday, September 26, 2019
Torrent is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets to the consumer level.
read more
Friday, September 27, 2019
GlaxoSmithKline (GSK) has completed a $120 million expansion of its manufacturing site in the Philadelphia suburb of Upper Merion, PA.
read more